Sunshine Biopharma (SBFM) Stock Statistics & Valuation Metrics

Sunshine Biopharma has a market cap or net worth of $2.59M. The enterprise value is -$3.76M.

Sunshine Biopharma has 5,005,945 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sunshine Biopharma’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -18.78%.

The current PE Ratio of Sunshine Biopharma is ―. Sunshine Biopharma’s PEG ratio is 0.01.

In the last 12 months, Sunshine Biopharma had revenue of 36.31M and earned -5.98M in profits. Earnings per share was -1.44.

In the last 12 months, operating cash flow was -5.69M and capital expenditures 180.78K, giving a free cash flow of -5.51M billion.

Sunshine Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Sunshine Biopharma upcoming earnings date is Aug 5, 2026, After Close (Confirmed).

Sunshine Biopharma as a current ratio of 4.17, with Debt / Equity ratio of 3.46%

In the past 12 months, Sunshine Biopharma has paid 21.61K in taxes.

Sunshine Biopharma EV to EBITDA ratio is 0.77, with an EV/FCF ratio of 0.58.

Sunshine Biopharma has $6.91M in cash and marketable securities with $744.84K in debt, giving a net cash position of $6.17M billion.

Gross margin is 32.49%, with operating margin of -12.34%, and net profit margin of -16.46%.

The average price target for Sunshine Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―